SCHEMBL14050535

SCHEMBL14050535

COCCCNS(=O)(=O)Cc1cccc([N+](=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
HPGD P15428 3/20 0.47
MAPK1 P28482 1/20 0.45
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 5/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
NPC1 O15118 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
GSTO1 P78417 1/20 0.37
HTT P42858 1/20 0.37
CYP2C19 P33261 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2989262 0.87 KMT2A (0.52) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL14039758 0.84 ALDH1A1 (0.42) ALDH1A1HPGDMEN1KMT2ACYP2C19
SCHEMBL16509294 0.81 ALDH1A1 (0.51) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL2986910 0.80 ALDH1A1 (0.50) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL14039455 0.79 ALKBH5 (0.39) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL4428122 0.79 MEN1 (0.54) ALDH1A1MEN1KMT2AL3MBTL1LMNA
SCHEMBL4601571 0.79 ALDH1A1 (0.70) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL14039537 0.78 ALDH1A1 (0.48) ALDH1A1HPGDMAPK1MEN1KMT2A
SCHEMBL19220492 0.74 TSHR (0.39) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL5819265 0.74 MEN1 (0.49) ALDH1A1HPGDMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008129080-A1 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2008-10-30 WO disclosed